Bridgebio Oncology Therapeutics, Inc. (BBOT)
8.73
-0.02
(-0.23%)
USD |
NASDAQ |
May 19, 16:00
8.73
0.00 (0.00%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics EPS Diluted (Quarterly) : -526.11 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Praxis Precision Medicines, Inc. | -3.205 |
| Bicara Therapeutics, Inc. | -0.9258 |
| Amgen, Inc. | 3.344 |
| BioMarin Pharmaceutical, Inc. | 0.5431 |
| Gilead Sciences, Inc. | 1.612 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.11M |
| Total Expenses (Quarterly) | 42.11M |
| Enterprise Value | 451.31M |
| Earnings Yield | -6.04K% |
| Normalized Earnings Yield | -6043.41 |